What do you assess for with fetal Non-Stress Test (NST) in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What the Fetal Non-Stress Test (NST) Assesses

The NST assesses acute fetal well-being by evaluating the integrity of the fetal autonomic nervous system through monitoring fetal heart rate accelerations in response to fetal movement. 1, 2

Primary Assessment Parameters

The NST specifically evaluates:

  • Fetal heart rate accelerations - The presence of at least 2 accelerations of ≥15 beats/minute above baseline, lasting ≥15 seconds, within a 20-minute period (at ≥32 weeks gestation) indicates a reactive test and confirms adequate fetal oxygenation and acid-base balance 1, 2

  • Fetal autonomic nervous system function - Heart rate accelerations serve as a surrogate measure of the developing fetal autonomic nervous system, with reactivity indicating intact central nervous system function 3

  • Immediate fetal oxygenation status - The NST provides real-time assessment of acute fetal well-being, distinguishing it from chronic markers like amniotic fluid volume 4, 1

What the NST Does NOT Assess

Critical limitation: The NST cannot predict stillbirth from acute catastrophic events such as placental abruption or cord accidents, regardless of how recently the test was performed or how frequently it is repeated. 1, 2

The NST alone does not evaluate:

  • Amniotic fluid volume - This requires separate ultrasound assessment and reflects chronic placental function over the preceding week 4, 1
  • Fetal growth - Biometry is needed to assess for growth restriction 4
  • Fetal anatomy or structural abnormalities 1
  • Placental function beyond acute oxygenation 1

Clinical Performance Characteristics

  • High negative predictive value (>99.9%) - A reactive NST is highly reassuring, with stillbirth risk of only 0.8 per 1,000 cases (0.08%) within one week 1

  • Better specificity than sensitivity - The NST is more reliable at confirming fetal health than detecting fetal compromise, making it an excellent screening tool but requiring additional testing when nonreactive 3

  • False negatives are uncommon but possible - Fetal deaths have occurred within 7 days of reactive NSTs (0.026% in one series), typically from cord accidents or abruption 5

Modified Biophysical Profile Context

When combined with amniotic fluid assessment, the NST becomes a "modified biophysical profile" that evaluates both acute (NST) and chronic (amniotic fluid) markers of fetal well-being. 4, 1 This combination is the recommended approach rather than NST alone, as oligohydramnios is an independent risk factor for stillbirth that the NST cannot detect 1.

Common Pitfall

The most frequent cause of a nonreactive NST is fetal sleep cycles (lasting 20-40 minutes), not fetal compromise 2. Always extend monitoring to 40 minutes before declaring a test nonreactive, and consider fetal acoustic stimulation to awaken the fetus 2.

References

Guideline

Fetal Well-being Assessment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Non-Stress Test Protocol for Fetal Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Principles of nonstress testing in pregnancy.

The Journal of family practice, 1996

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The nonstress test: the false negative test.

American journal of obstetrics and gynecology, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.